Vertex Pharmaceuticals filed a 10-Q (Quarterly Report) with the SEC. — Filed Aug 4, 2026 · period ended Jun 30, 2026 · accession 0000875320-26-000259.
Item 2.02 Results of Operations and Financial Condition · Item 9.01 Financial Statements and Exhibits — Filed Aug 3,…
Item 5.02 Departure or Election of Directors and Officers — Filed Sep 1, 2026 · event date Aug 27, 2026 · accession…
Item 1.01 Entry into a Material Definitive Agreement · Item 7.01 Regulation FD Disclosure · Item 8.01 Other Events ·…
Item 5.02 Departure or Election of Directors and Officers · Item 5.07 Submission of Matters to a Vote of Security…